Back
ESC Premium Access

Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy

Session: Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy
Topic: Treatment
Speaker: Doctor C. Fumagalli (Florence, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Carlo Fumagalli

Careggi University Hospital (AOUC), Florence (Italy)
0 follower

9 more presentations in this session

Predictors of ACEI/ ARB therapy in patients with hypertrophic cardiomyopathy: results of a national registry.

Speaker: Assistant Professor E. Martins (Porto, PT)

Access
Abstract
Like
Thumbnail

Result of surgical treatment of obstructive hypertrophic cardiomyopathy with coronary heart disease

Speaker: Doctor Y. Meng (Beijing, CN)

Access
Like
Thumbnail

Comparative effectiveness of alcohol septal ablation versus septal myectomy on acute cardiovascular events in patients with hypertrophic cardiomyopathy

Speaker: Associate Professor H. Takayama (New York, US)

Access
Abstract
Like
Thumbnail

Predictors of long-term outcome after rescue surgical septal myectomy in hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation

Speaker: Doctor C. Zhu (Beijing, CN)

Access
Abstract
Like
Thumbnail

Clinical significance of impaired cardiac conduction after alcohol septal ablation

Speaker: Mr M. Jensen (Aarhus, DK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy

Speakers: Doctor C. Fumagalli, Assistant Professor E. Martins, Doctor Y. Meng, Associate Professor H. Takayama, Doctor C. Zhu...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources